Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2B P/E - EPS this Y -17.60% Ern Qtrly Grth -
Income -153.3M Forward P/E -11.57 EPS next Y -23.30% 50D Avg Chg -3.00%
Sales 33.05M PEG -0.43 EPS past 5Y - 200D Avg Chg -22.00%
Dividend N/A Price/Book 1.66 EPS next 5Y 10.00% 52W High Chg -54.00%
Recommedations 1.90 Quick Ratio 10.49 Shares Outstanding 294.67M 52W Low Chg 25.00%
Insider Own 28.05% ROA -11.41% Shares Float 188.55M Beta 0.37
Inst Own 41.51% ROE -13.30% Shares Shorted/Prior 16.84M/18.17M Price 6.94
Gross Margin - Profit Margin - Avg. Volume 3,156,685 Target Price 15.43
Oper. Margin -1,276.17% Earnings Date Nov 4 Volume 2,224,034 Change -4.54%
About AbCellera Biologics Inc.

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc. News
11/07/24 AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024
11/07/24 AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates
11/06/24 AbCellera Biologics Third Quarter 2024 Earnings: Misses Expectations
11/05/24 Q3 2024 Abcellera Biologics Inc Earnings Call
11/05/24 AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...
11/04/24 AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript
11/04/24 AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Misses Revenue Estimates
11/04/24 AbCellera Reports Q3 2024 Business Results
10/22/24 AbCellera to Present at Upcoming Investor Conferences in November 2024
10/21/24 3 Promising Penny Stocks On US Exchanges With Over $600M Market Cap
10/16/24 Is AbCellera Biologics Inc. (ABCL) the Penny Stock with the Biggest Upside Potential According to Analysts?
10/04/24 AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024
09/26/24 AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024
09/01/24 AbCellera Biologics Inc. (ABCL): The Best Multibagger Penny Stock of 2025?
08/31/24 Carl Hansen Buys Handful Of Shares In AbCellera Biologics
08/29/24 AbCellera to Present at Upcoming Investor Conferences in September
08/29/24 AbCellera Biologics Inc. (ABCL): A Top Contender Among Canada’s Best Penny Stocks in 2024
08/11/24 Need To Know: The Consensus Just Cut Its AbCellera Biologics Inc. (NASDAQ:ABCL) Estimates For 2024
08/09/24 Earnings Update: AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Are Trimming Their Forecasts
08/07/24 AbCellera Biologics Inc.'s (NASDAQ:ABCL) latest 12% decline adds to one-year losses, institutional investors may consider drastic measures
ABCL Chatroom

User Image Ed_Ng Posted - 41 minutes from now

$ABCL same here!

User Image HeIsHavingHisBath Posted - 37 minutes from now

$ABCL Just thought I'd say my weekly, "Worst stock of my life," whine.

User Image Plutten1973 Posted - 1 hour ago

$ABCL someday but not today I can wait have no hurry

User Image DeMampCamp Posted - 2 hours ago

$ABCL Back above the 50ma, 20ma is at $2.80, let's get above it

User Image Ed_Ng Posted - 4 hours ago

$ABCL yes. Trending down for 3 years is not acceptable

User Image FreyBentos Posted - 5 hours ago

$ABCL how it feels investing in abcl

User Image Ed_Ng Posted - 5 hours ago

$ABCL again!

User Image Eurofighter Posted - 5 hours ago

$ABCL Stifel Healthcare Conference on Monday, November 18, 2024, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time) Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 10:00 a.m. Pacific Time (5:00 p.m. Greenwich Mean Time)

User Image Eurofighter Posted - 5 hours ago

$ABCL what a c*nt

User Image snowPOW Posted - 17 hours ago

$ABCL old article for a refresher https://www.biv.com/news/technology/abcellera-admare-deliver-capital-and-rd-boost-bc-cancer-therapy-startup-abdera-8263024

User Image snowPOW Posted - 17 hours ago

$ABCL https://www.cbc.ca/news/health/cancer-treatment-research-targeted-alpha-therapy-1.7384434

User Image superdupersocks Posted - 3 days ago

$ABCL RFK effect?

User Image extremejd Posted - 3 days ago

$ABCL patience with this company is not rewarded 😔. What a waste of money

User Image Eurofighter Posted - 3 days ago

$ABCL mf dog shit stock. Hansen...as soon i see you...we ll talk. Not ending happily for you

User Image Ed_Ng Posted - 3 days ago

$ABCL they lied to you us

User Image peteyg33 Posted - 3 days ago

$ABCL hansen ty for all your great hype....hope y can sleep at night i dont....

User Image hichemben Posted - 3 days ago

$ABCL I appreciate everyone is not happy with the setback from last week, but nothing changed and the post below about institutions sold in Q3 that’s a very small number of shares (1% each). Baker Bros still holding, CEO majority shareholder and few other insiders. There is no catalyst until mid 2025, until then we might get back over $3 to $4. If you can’t handle this, then cut your loss 🙌🏻 I’m Bulish🚀

User Image Bromberger Posted - 3 days ago

$ABCL to understand why we are down today

User Image Ed_Ng Posted - 3 days ago

$ABCL omg. Is it true?

User Image NorthShoreTrader2021 Posted - 3 days ago

$ABCL Founders Fund ( Peter Thiel's fund), Capital World Investors, BAILLIE GIFFORD & CO, Morgan Stanley, Norges Bank, ... have sold over 20 million shares in Q3,2024. Most of them sold out 100%. I don't think the incoming JFK jr as health minister help the biotech sector in general.

User Image FreyBentos Posted - 3 days ago

$ABCL just wait for sub $2 if yourbthinking of averaging down. Wall street going to oush this down further yet, stock will downtrend until the company creates a succesful mAB which shows pitential future income. Theres zero reason for this stock to go anywhere but down for the forseabke future, a company rhat makes no money, actually loses money every quarter, and has nothing at all to suggest any future earnings are coming. A complete dog of an investment, it could be another 4 years before they announce theyve had success with a treatment and have future revenues on the horizon.

User Image Eurofighter Posted - 3 days ago

$ABCL it is just a real piece of dogshit. Was a godd opportunity to get rid of this. Puuuuuh...mallakka

User Image DeMampCamp Posted - 3 days ago

$ABCL And per usual, we don't go up with the market, but we sure as hell go down with the market. Same bullshit, different day! Can't wait for the day this company has something more than aspirations and dreams, sigh! Enjoy your Friday and weekend my friends!

User Image sogenerous Posted - 3 days ago

$ABCL Please give us mid 1s here

User Image sogenerous Posted - 3 days ago

$ABCL if it goes a little lower bottom wasn't in. Please take this to 1s as a F.U to mgmt

User Image tkstockpicker Posted - 3 days ago

$ABCL back in at 2.70

User Image Ed_Ng Posted - 3 days ago

$ABCL that's it!

User Image Plutten1973 Posted - 3 days ago

$ABCL Feels like retest about 2.65 area 😪

User Image ggoggo Posted - 3 days ago

$ABCL How the mighty have fallen

User Image Abcl2028 Posted - 3 days ago

$ABCL can someone check whether they have retained same value of shares.

Analyst Ratings
Benchmark Hold Aug 20, 24
Keybanc Overweight Jul 11, 24
Keybanc Overweight May 8, 24
Benchmark Buy Feb 22, 24
Stifel Buy Feb 21, 24
Keybanc Overweight Dec 5, 23
Benchmark Buy Aug 31, 23
Goldman Sachs Buy Aug 4, 23
Credit Suisse Outperform May 5, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Montalbano John S. Director Director Nov 06 Buy 4.55 30,000 136,500 86,000 11/08/23
Hayden Michael R Director Director Sep 22 Buy 4.91 20,000 98,200 1,323,397 09/26/23
Lecault Veronique Chief Operating Offi.. Chief Operating Officer Sep 12 Buy 5.19 20,000 103,800 2,040,122 09/14/23
Hayden Michael R Director Director Aug 08 Buy 5.90 30,000 177,000 1,303,397 08/09/23
Booth Andrew Chief Financial Offi.. Chief Financial Officer Dec 20 Option 0.19 50,000 9,500 188,500 12/22/22
Thermopylae Holdings Ltd. 10% Owner 10% Owner Dec 16 Buy 10.0967 85,102 859,249 55,859,493 12/20/22
Hansen Carl L. G. Chief Executive Offi.. Chief Executive Officer Nov 18 Option 2.70 56,125 151,538 449,000 11/21/22
Thermopylae Holdings Ltd. 10% Owner 10% Owner Aug 19 Buy 11.4623 200,000 2,292,460 55,844,391 08/22/22
Hansen Carl L. G. Chief Executive Offi.. Chief Executive Officer Aug 18 Option 2.70 56,125 151,538 392,875 08/22/22
Thermopylae Holdings Ltd. 10% Owner 10% Owner Jun 13 Buy 8.04 64,088 515,268 55,644,391 06/15/22
Thermopylae Holdings Ltd. 10% Owner 10% Owner Jun 06 Buy 7.4981 64,545 483,965 55,580,303 06/08/22
Hansen Carl L. G. Chief Executive Offi.. Chief Executive Officer May 18 Option 2.70 56,125 151,538 336,750 05/19/22
Lecault Veronique Chief Operating Offi.. Chief Operating Officer May 16 Buy 6.3389 200,000 1,267,780 1,770,122 05/17/22
Thermopylae Holdings Ltd. 10% Owner 10% Owner May 13 Buy 7.2551 300,000 2,176,530 55,515,758 05/17/22
Montalbano John S. Director Director Mar 01 Buy 9.05 20,000 181,000 46,000 03/03/22
Lecault Veronique Chief Operating Offi.. Chief Operating Officer Feb 28 Buy 8.66 230,789 1,998,633 1,570,122 03/01/22
Hansen Carl L. G. Chief Executive Offi.. Chief Executive Officer Feb 22 Option 2.70 56,125 151,538 280,625 02/25/22
Booth Andrew Chief Financial Offi.. Chief Financial Officer Nov 11 Buy 14.68 67,500 990,900 130,959 11/15/21